Direct hit on the first afternoon of the national talks in 2025: Pfizer, Qilu, and many other Chinese and foreign companies enter the field.

The negotiation for the National Medical Insurance Catalogue in 2025 officially started today. Reporters at the scene learned that around 1:30 PM, participating companies included Boehringer Ingelheim, Pfizer, Qilu Pharmaceutical, Kangyuan Pharmaceutical, Bayer, Shengdi Medicine, Fosun Pharma, and Merck. In the morning, companies such as Lijun Pharmaceutical, Xinda Biotechnology, Roche, and AstraZeneca also participated.